Prior authorization decisions typically take 1-2 weeks if documentation is complete
While both medications work similarly, Tirzepatide also targets another hormone, GIP (glucose-dependent insulinotropic polypeptide), which may offer additional weight loss benefits
The cardioprotective effects of GLP-1 RAs in patients diagnosed with type 2 diabetes, alongside associated reductions in cardiovascular risk factors, such as glycated hemoglobin level and BMI are now further elucidated by our findings 17,22,26
Many researchers who switched from morning to evening injection report dramatically improved quality of life, not because the side effects disappeared, but because they simply did not experience them consciously
A second paper, published in 1987, was a landmark: The tests showed that GLP-1 led to insulin secretion